Tag Archives: metabolic health

Why BMI Is Outdated: Android Fat, Low Testosterone, and Real Disease Risks

Why BMI Is Outdated and Should Be Eliminated: Android Fat Distribution, Low Testosterone, and Real Disease Risks Body Mass Index (BMI) has long been the default tool for evaluating weight-related health risks, but it is deeply flawed, outdated, and misleading. Calculated simply as weight in kilograms divided by height squared (kg/m²), BMI fails to distinguish…
Read more

Tirzepatide: The Recomp King – Superior Fat Redistribution, Lean Mass Preservation, and True Body Recomposition

Tirzepatide: The Recomp King – Optimizing Fat Distribution, Preserving & Building Lean Mass, and Delivering True Recomposition Tirzepatide (Mounjaro / Zepbound), a dual GLP-1/GIP receptor agonist with pronounced GIP activity, has redefined what is possible in the treatment of obesity, type 2 diabetes, and insulin resistance. Beyond impressive total weight loss, tirzepatide excels at improving…
Read more

Why Tirzepatide Is Superior to Retatrutide: The GIP Advantage for Insulin Sensitivity and Beyond

Why Tirzepatide Is Superior to Retatrutide: The GIP Advantage for Insulin Sensitivity and Beyond In the rapidly advancing field of metabolic therapies, Tirzepatide (Mounjaro/Zepbound) and the investigational Retatrutide stand out as powerful tools for treating obesity, type 2 diabetes, and insulin resistance. While both deliver impressive results, Tirzepatide holds a clear edge thanks to its…
Read more

How TRT Helps Men Reduce or Eliminate Statins & SSRIs with High-Normal Testosterone

How TRT Helps Men Reduce or Eliminate Statins & SSRIs with High-Normal Testosterone For many men taking statins for high cholesterol or SSRIs for depression and anxiety, TRT statins SSRIs connections are becoming clearer: optimizing testosterone levels to the high-normal range (typically 800–1200 ng/dL) through Testosterone Replacement Therapy (TRT) often leads to significant improvements in…
Read more

ARA-290 (Cibinetide) for Inflammation Relief in Hypogonadal Men

ARA-290 (Cibinetide) for Inflammation Relief in Hypogonadal Men ARA-290 (Cibinetide) inflammation relief is gaining attention as a supportive peptide for hypogonadal men on testosterone replacement therapy (TRT). This non-erythropoietic EPO-derived peptide selectively activates tissue repair pathways, reducing inflammation and promoting nerve health without affecting red blood cell production. Men on TRT experiencing inflammation-related issues like…
Read more

NAD+ Therapy for Anti-Aging: Injectable, Troches & Nasal Spray

NAD+ Therapy: Boosting Cellular Energy and Anti-Aging Vitality NAD+ therapy restores levels of nicotinamide adenine dinucleotide (NAD+), an essential coenzyme present in every cell that drives mitochondrial energy production, DNA repair, metabolic regulation, and sirtuin activation to support cellular health and longevity. As people age, NAD+ levels drop significantly—often by 50% or more—leading to mitochondrial…
Read more

Tirzepatide Beyond the Scale: Fertility and Hormones in Men and Women

Tirzepatide Beyond the Scale: Hormones and Fertility in Men and Women Tirzepatide, a dual GLP-1/GIP receptor agonist (brand names Mounjaro or Zepbound), is FDA-approved for type 2 diabetes and chronic weight management. Emerging research reveals its direct impact on hormonal balance through receptor activation in endocrine and reproductive tissues, leading to elevated sex hormones and…
Read more

Tirzepatide Boosts Fertility and Sex Hormones in Both Men and Women: The Latest Science

Tirzepatide: Reviving Fertility and Balancing Sex Hormones for Men and Women If you're dealing with stubborn weight, low energy, hormonal imbalances, or fertility challenges tied to obesity or metabolic issues, tirzepatide (the dual-action powerhouse in Mounjaro and Zepbound) could be a breakthrough. Emerging evidence reveals it doesn't just drive massive weight loss—it directly supports reproductive…
Read more

Tesamorelin: The FDA-Approved Peptide for Reducing Visceral Belly Fat

Tesamorelin: The Only FDA-Approved Treatment for Reducing Dangerous Visceral Belly Fat Visceral fat—the deep abdominal fat surrounding vital organs like the liver, pancreas, and intestines—is metabolically active and far more harmful than subcutaneous fat (the pinchable layer under the skin). It drives inflammation, insulin resistance, type 2 diabetes, cardiovascular disease, and non-alcoholic fatty liver disease…
Read more